**Core Concept**
The question pertains to the mechanism of action of antipsychotic medications, specifically their effects on neurotransmitter systems in the brain. Antipsychotics primarily act by modulating dopamine and serotonin receptors, leading to a reduction in psychotic symptoms.

**Why the Correct Answer is Right**
Antipsychotics, particularly the first-generation or typical antipsychotics, primarily block dopamine D2 receptors in the mesolimbic pathway. This blockade leads to a decrease in dopamine release and a subsequent reduction in psychotic symptoms. The mesolimbic pathway is involved in the regulation of emotions, motivation, and reward processing. By blocking dopamine receptors in this pathway, antipsychotics can help alleviate symptoms of psychosis, such as hallucinations and delusions.

**Why Each Wrong Option is Incorrect**
**Option A:** This statement is incorrect because it does not specify the correct receptor subtype or pathway involved in the mechanism of action of antipsychotics.
**Option B:** This statement is incorrect because it inaccurately suggests that antipsychotics primarily act by blocking serotonin receptors, which is not their primary mechanism of action.
**Option C:** This statement is incorrect because it mentions the "mesocortical pathway," which is not the primary pathway involved in the mechanism of action of antipsychotics.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that the first-generation antipsychotics, such as haloperidol, primarily block dopamine D2 receptors, whereas the second-generation antipsychotics, such as risperidone, have a higher affinity for serotonin 5-HT2A receptors, which contributes to their therapeutic effects and side effect profiles.

**Correct Answer: D. The mesolimbic pathway is primarily involved in the regulation of emotions and motivation.**